Skip to main content
Celyad Oncology SA logo

Celyad Oncology SA — Investor Relations & Filings

Ticker · CYAD ISIN · BE0974260896 LEI · 549300ORR0M8XF56OI64 BR Professional, scientific and technical activities
Filings indexed 923 across all filing types
Latest filing 2026-04-02 Regulatory Filings
Country BE Belgium
Listing BR CYAD

About Celyad Oncology SA

https://celyad.com/

Celyad Oncology is a biotechnology company primarily focused on unlocking the potential of its intellectual property in the field of cell therapy. The company discovers and develops innovative technologies for Chimeric Antigen Receptor T-cell (CAR-T) therapies aimed at treating cancer. Its differentiated strategy includes the advancement of proprietary technology platforms and CAR T-cell candidates designed to broaden the range of treatable cancer indications and overcome the main limitations of existing CAR T-cell therapies.

Recent filings

Filing Released Lang Actions
FINAL Celyad_English_ARA 2025_Final 20260402.pdf
Regulatory Filings
2026-04-02 English
FINAL Celyad_French_ARA_2025-Final 20260402.pdf
Regulatory Filings
2026-04-02 French
celyadoncology-2025-12-31-1-en.xhtml
Annual Report
2026-04-02 French
celyadoncology-2025-12-31-1-en.xbri
Annual Report
2026-04-02 French
Final clean 20260402_CYAD - PR FY Financial Results 2025 EN (5) DGEO BDO.pdf
Regulatory Filings
2026-04-02 English
Final clean 20260402_CYAD - PR FY Financial Results 2025 FR (5) DGEO BDO.pdf
Regulatory Filings
2026-04-02 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.